Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.2 updated from the previous version v3.5.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This seems to reflect a system version update with no apparent changes to the study details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.2; removed the government operating-status notice and the previous Revision: v3.4.1 banner.SummaryDifference0.5%

- Check74 days agoChange DetectedTwo additions include a government funding notice and a new revision label (Revision: v3.4.1), while the previous revision label (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedThe changes include a UI enhancement to show the glossary, capitalization adjustments in a QC-related label, and a version label update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.